查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853992

癌症资讯系统市场按服务产品、功能、部署类型、应用和最终用户划分－全球预测，2025-2032年

Oncology Information Systems Market by Offering, Functionality, Deployment Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，癌症资讯系统市场规模将达到 134.2 亿美元，复合年增长率为 7.78%。

关键市场统计数据
基准年2024年 73.7亿美元
预计年份：2025年 79.1亿美元
预测年份 2032 134.2亿美元
复合年增长率 (%) 7.78%

在精准医疗、互通性要求和以病人为中心的数位化照护路径驱动下，驾驭不断变化的肿瘤学生态系统

癌症诊疗流程正受到技术、临床和监管因素的重塑，这些因素对资讯管理提出了新的要求。医护人员需要在日益复杂的治疗方法与收集和整合多源临床数据之间寻求平衡，因此，肿瘤资讯系统的角色正在从行政支援转向策略基础设施。在此背景下，领导者不仅需要了解产品功能，还需要了解系统如何整合诊疗路径、支援多学科团队并维持长期的互通性。

临床医生和管理人员目前都在寻求能够减轻认知负荷、加快决策速度并实现肿瘤特定工作流程和企业IT资产之间无缝资料交换的平台。随着精准肿瘤学的扩展，对能够将化疗管理、放射治疗计划、影像整合、实验室数据和纵向电子健康记录整合到统一用户体验中的解决方案的需求也日益增长。因此，那些展现出临床疗效、易于整合且能显着提升病患安全和营运效率的系统，在投资决策中越来越受到重视。

本导言透过重点阐述这些趋势对供应商、医疗系统和政策制定者的策略影响，为后续分析组装。它指出了关键曲折点，探讨了基于细分市场的产品策略的影响，并概述了领导者可以采取哪些立即行动，以使技术应用与以患者为中心的护理目标保持一致。

找出正在影响肿瘤学技术应用的变革性转变，包括人工智慧诊断、云端原生架构和临床医生工作流程重组。

癌症资讯系统领域正经历一场变革性的转变，其影响远不止于产品功能的提升，而是涵盖了全新的交付模式、分析范式和临床工作流程。人工智慧和先进的视觉化技术正被引入临床实践，以提高诊断的准确性并辅助病例优先排序；同时，临床决策支援系统正被深度融入治疗计划和排班流程，以减少治疗方案的差异性并提高指南的依从性。同时，云端原生技术的应用也在加速发展，使分散的团队能够存取统一的病患记录，并实现临床内容和法规遵循模组的快速更新。

互通性仍然是变革的核心。新的标准和应用程式介面（API）正在降低将实验室资讯系统、影像檔案库、放射治疗计划软体和电子肿瘤病历整合到统一的临床流程中的门槛。这种转变促使供应商采用模组化、API优先的架构，并寻求与临床整合商和影像专家建立伙伴关係。临床医生期望获得支援多学科协作的直觉使用者介面，而医疗系统则在培训和变革管理方面投入资源，以确保技术的普及应用并切实提高患者安全。

总而言之，这些变更正在重新定义供应商的相关性和买家的期望。拥有强大的临床检验、灵活的部署方案和清晰的实施蓝图的机构，最能支援不断发展的医疗模式，并在临床和营运方面实现可衡量的改善。

评估2025年美国关税对肿瘤资讯系统供应链和服务的累积营运和采购影响

美国2025年关税政策的实施，为肿瘤资讯系统供应商及其客户的采购和供应链规划带来了新的变数。虽然软体本身俱有可移植性，但涵盖广泛的肿瘤IT价值链还包括硬体、影像设备、专用伺服器和整合服务，这些都对贸易政策十分敏感。因此，关税主导的成本压力迫使采购团队重新评估其供应商选择、整体拥有成本以及设备和服务交付的紧急策略。

在营运方面，医疗系统和技术供应商已采取措施应对，包括分散供应商管道，并尽可能加快实体基础设施的在地采购。这促使他们更加重视检验能够最大限度减少对受关税影响组件依赖的配置方案，优化虚拟化和云端託管功能，并重新协商服务等级协定以应对潜在的供应延迟。同时，一些供应商调整了商业模式，透过提供配套服务、延长保固或组建本地安装团队来分担部分增加的负担。

关税的影响远不止于直接的采购策略；它也影响着围绕製造在地化、合约灵活性和投资优先顺序的策略讨论。企业越来越重视供应链的韧性，将其纳入供应商选择标准，倾向选择那些采购透明、物流能力强、紧急时应对计画完善的合作伙伴。这些调整反映出产业普遍认识到，政策主导的成本动态会对部署进度、计划利润和营运风险产生重大影响。

将细分洞察转化为可执行的产品和服务策略，涵盖产品、功能、部署类型、应用程式和最终用户群。

对市场区隔的深入理解对于使产品开发和市场推广策略与临床及营运需求保持一致至关重要。服务包括咨询与培训、安装与整合以及维护与支持，而解决方案则包括化疗资讯系统、临床整合解决方案、实验室资讯系统 (LIS)、医学影像分析与高级视觉化、肿瘤电子健康记录(EHR)、影像归檔与通讯系统 (PACS) 和厂商中立归檔系统 (VNA)、放射治疗计划系统以及影像放射资讯系统 (RIS)。这种双重性凸显了买家采购的是一系列功能和实施专业知识的组合，而非独立的产品。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧驱动的预测分析整合到癌症资讯系统中，以实现个人化治疗计划。
  • 将全面的基因组序列资料整合到肿瘤智慧平台中，以实现精准医疗。
  • 云端基础的癌症资讯系统，可实现多学科护理团队之间的安全远端协作。
  • 实施 HL7 FHIR互通性标准，实现肿瘤数据无缝交换与报告
  • 先进的患者报告结果追踪模组可提供癌症护理中生活品质的即时资讯。
  • 利用机器学习演算法，透过电子肿瘤记录预测药物不良反应，以改善安全监测。
  • 将远距肿瘤虚拟医疗整合到癌症资讯系统中，以扩大农村患者的就医途径和支持。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 癌症资讯系统市场依产品/服务分类

  • 服务
    • 咨询和培训
    • 安装与集成
    • 维护和支援
  • 解决方案
    • 化疗资讯系统
    • 临床整合解决方案
    • 实验室资讯系统（LIS）
    • 医疗图像分析与进阶视觉化
    • 肿瘤电子健康纪录（EHR）
    • 图片归檔与通讯系统 (PACS) 和厂商中立归檔系统 (VNA)
    • 放射治疗计划系统
    • 放射资讯系统（RIS）

第九章 按功能分類的癌症资讯系统市场

  • 计费和收益周期管理
  • 临床决策支持
  • 病人资讯和护理管理
  • 监理合规与报告
  • 治疗计划和安排

第十章 依部署模式分類的癌症资讯系统市场

  • 云端基础的
  • 本地部署

第十一章 按应用分類的癌症资讯系统市场

  • 肿瘤内科
  • 放射肿瘤学
  • 外科肿瘤学

第十二章 依最终用户分類的癌症资讯系统市场

  • 消融和癌症护理中心
  • 医院和诊断影像中心
  • 研究设施

第十三章 各地区癌症资讯系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 癌症资讯系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国癌症资讯系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Accuray Incorporated
    • Advanced Data Systems Corporation
    • CompuGroup Medical, Inc.
    • CureMD.com, Inc.
    • DOSIsoft SA
    • Elekta AB
    • EndoSoft LLC by Utech Products Inc.
    • Epic Systems Corporation
    • F. Hoffmann-La Roche Ltd.
    • FUJIFILM Corporation
    • GE HealthCare Technologies Inc.
    • International Business Machines Corporation
    • Karkinos Healthcare Private Limited
    • McKesson Corporation
    • Medical Information Technology, Inc.
    • MICA Information Systems, Inc.
    • N-Power Medicine, Inc.
    • NextGen Healthcare, Inc.
    • Novarad Corporation
    • Oracle Corporation
    • RaySearch Laboratories
    • Royal Philips
    • Tempus AI, Inc.
    • Varian Medical Systems, Inc. by Siemens Healthineers AG
Product Code: MRR-0D217D5AE6B4

The Oncology Information Systems Market is projected to grow by USD 13.42 billion at a CAGR of 7.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.37 billion
Estimated Year [2025] USD 7.91 billion
Forecast Year [2032] USD 13.42 billion
CAGR (%) 7.78%

Navigating a transforming oncology information ecosystem driven by precision medicine, interoperability imperatives, and patient-centric digital care pathways

The oncology care continuum is being reshaped by converging technological, clinical, and regulatory forces that demand new forms of information management. Providers are balancing rising complexity in treatment regimens with an imperative to capture and harmonize multi-source clinical data, and as a result the role of oncology information systems has shifted from administrative enablers to strategic infrastructure. In this context, leaders must understand not only product capabilities but how systems integrate across care pathways, support multidisciplinary teams, and sustain long-term interoperability.

Clinicians and administrators are now asking for platforms that reduce cognitive load, accelerate decision making, and enable seamless data exchange across oncology-specific workflows and enterprise IT estates. As precision oncology expands, so too does the requirement for solutions that combine chemotherapy management, radiation planning, imaging integration, laboratory data, and longitudinal electronic health records into coherent user journeys. Consequently, investment decisions increasingly prioritize systems that demonstrate clinical efficacy, ease of integration, and measurable improvements in patient safety and operational efficiency.

This introduction frames the ensuing analysis by highlighting the strategic consequences of these trends for vendors, health systems, and policymakers. The focus that follows is practical and operational: identifying critical inflection points, examining segmentation-driven implications for product strategy, and outlining immediate actions that leaders can take to align technology adoption with patient-centered care objectives

Identifying transformative shifts reshaping oncology technology adoption including AI-enabled diagnostics, cloud-native architectures, and clinician workflow reengineering

The landscape of oncology information systems is experiencing transformative shifts that extend beyond incremental product enhancements to encompass new delivery models, analytic paradigms, and clinical workflows. Artificial intelligence and advanced visualization are moving into clinical practice, augmenting diagnostic confidence and helping prioritize cases, while clinical decision support is becoming more deeply embedded into treatment planning and scheduling to reduce variability and improve guideline adherence. Parallel to this, cloud-native deployments are accelerating, enabling distributed teams to access consolidated patient records and facilitating faster updates to clinical content and regulatory compliance modules.

Interoperability remains a central axis of change. New standards and APIs are lowering the barriers to connecting laboratory information systems, imaging archives, radiation planning software, and oncology electronic records into cohesive clinical flows. This shift encourages vendors to adopt modular, API-first architectures and to pursue partnerships with clinical integrators and imaging specialists. At the same time, workforce implications are profound: clinicians expect intuitive user interfaces that support multidisciplinary collaboration, and health systems are investing in training and change management to secure adoption and realize projected patient safety gains.

Taken together, these shifts are redefining vendor relevance and buyer expectations. Organizations that combine strong clinical validation, flexible deployment options, and clear implementation roadmaps will be best positioned to support evolving care models and to deliver measurable improvements in both clinical and operational outcomes

Assessing the cumulative operational and procurement impacts of United States tariff measures enacted in 2025 on oncology information system supply chains and services

Tariff measures introduced in the United States in 2025 have introduced a new variable into procurement and supply chain planning for oncology information system providers and their customers. While software is inherently portable, the broader value chain for oncology IT encompasses hardware, imaging equipment, specialized servers, and integration services that are sensitive to trade policy. As such, tariff-driven cost pressures have required procurement teams to re-evaluate vendor sourcing, total cost of ownership, and contingency strategies for equipment and service delivery.

Operationally, health systems and technology vendors have responded by diversifying supplier footprints and accelerating local sourcing for physical infrastructure where feasible. This has led to renewed emphasis on validating configurations that minimize dependence on tariff-exposed components, optimizing virtualized and cloud-hosted functions, and renegotiating service-level agreements to account for potential supply delays. In parallel, some vendors have adjusted commercial models to absorb part of the incremental burden through bundled service offerings, extended warranties, or localized installation teams.

Beyond immediate procurement tactics, tariffs have also influenced strategic conversations around manufacturing localization, contractual flexibility, and investment prioritization. Organizations are increasingly factoring supply chain resilience into vendor selection criteria, preferring partners that demonstrate transparent sourcing, robust logistics capabilities, and established contingency plans. These adaptations reflect a broader industry recognition that policy-driven cost dynamics can materially affect deployment timelines, project margins, and operational risk profiles

Translating segmentation intelligence into practical product and service strategies across offerings, functionalities, deployment modes, applications, and end user profiles

A nuanced understanding of segmentation is essential for aligning product development and go-to-market strategies with clinical and operational needs. Based on Offering, the landscape divides into Services and Solution, where Services include Consulting & Training, Installation & Integration, and Maintenance & Support, and Solution encompasses Chemotherapy Information System, Clinical Integration Solutions, Laboratory Information Systems (LIS), Medical Image Analysis & Advanced Visualization, Oncology Electronic Health Record (EHR), Picture Archiving & Communication System (PACS) & Vendor-Neutral Archive (VNA), Radiation Treatment Planning System, and Radiology Information Systems (RIS). This duality underscores that buyers are procuring bundles of functionality plus implementation expertise rather than standalone products.

Based on Functionality, offerings range from Billing & Revenue Cycle Management to Clinical Decision Support, Patient Information & Care Management, Regulatory Compliance & Reporting, and Treatment Planning & Scheduling, indicating that commercial success depends on addressing both administrative and high-acuity clinical workflows. Based on Deployment Mode, choices between Cloud-Based and On-Premise continuums influence procurement cadence, security posture, and integration complexity, and these options must be reflected in commercial and technical roadmaps.

Based on Application, differentiation across Medical Oncology, Radiation Oncology, and Surgical Oncology requires product teams to prioritize domain-specific workflows and decision support. Finally, Based on End User, solutions must account for the distinct needs of Ablation & Cancer Care Centers, Hospitals & Diagnostic Imaging Centers, and Research Facilities. In practice, successful strategies translate this segmentation into modular product architectures, configurable workflows, and services that reduce integration burden while delivering measurable clinician and operational value

Deciphering regional adoption patterns and strategic imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific healthcare markets for oncology systems

Regional dynamics will increasingly dictate where and how oncology information systems are adopted, integrated, and scaled. In the Americas, health systems tend to prioritize interoperability with enterprise electronic health records, value-based care reporting, and advanced chemotherapy and radiation planning features, which drives demand for tightly integrated platforms and sophisticated clinical decision support. Procurement cycles in this region often emphasize contractual clarity, clinical validation, and demonstrable improvements in safety and throughput.

In Europe, Middle East & Africa, regulatory heterogeneity and diverse infrastructure maturity create opportunities for flexible deployment modes; cloud-based solutions can accelerate adoption in well-connected urban centers, while on-premise configurations remain important where data residency or bandwidth constraints persist. Regional priorities include harmonizing standards across health networks, supporting multilingual interfaces, and addressing local reimbursement and compliance frameworks.

In Asia-Pacific, rapid modernization of oncology services combined with significant private sector investment has spawned demand for scalable, cloud-enabled platforms and advanced imaging analytics. Markets in this region frequently value cost-effective, modular solutions that can be deployed quickly across multiple sites, alongside strong local implementation capabilities. Across all regions, successful vendors tailor propositions to local clinical practices, regulatory requirements, and procurement norms while supporting interoperability and clinician adoption through localized training and robust support models

Profiling competitive company behaviors and strategic moves that determine differentiation in oncology information systems including partnerships, integrations, and compliance focus

Company strategies in the oncology information systems space are converging on a few consistent themes: clinical validation, strategic partnerships, and platform extensibility. Leading vendors are investing in clinical studies and real-world evidence programs to demonstrate safety and workflow impact, while also seeking alliances with imaging specialists, laboratory providers, and systems integrators to deliver end-to-end solutions. At the same time, smaller, more agile companies are leveraging niche expertise in areas such as medical image analysis or radiation planning to gain footholds and to become attractive partners for larger platform vendors.

Commercial differentiation increasingly depends on the ability to provide certified interfaces and to support both cloud-based and on-premise deployments with clear security and compliance controls. Additionally, companies are refining pricing and service models to address the dual demands of capital-constrained providers and enterprise buyers seeking predictable operating costs. Talent acquisition and retention remain critical challenges; firms that can combine clinical informatics expertise with strong engineering teams will be better positioned to accelerate feature development and reduce time-to-deploy.

Mergers and partnerships continue to reshape competitive dynamics, but strategic success hinges on the ability to integrate disparate systems seamlessly, to back claims with clinical evidence, and to present a compelling value proposition to diverse end users including specialized cancer centers, hospital networks, and research institutions

Executive-level actionable recommendations to accelerate adoption, manage risk, and optimize commercial and clinical value from oncology information system investments

Industry leaders should adopt a prioritized, pragmatic set of actions that bridge clinical requirements and commercial viability. First, embed clinicians into product development cycles early and continuously, using structured clinical advisory boards and iterative usability testing to ensure that features align with real-world workflows and reduce cognitive burden. Second, adopt an API-first architecture and publish well-documented integration patterns to lower implementation friction and to enable faster interoperability with EHRs, LIS, PACS, and radiation planning tools.

Next, establish clear deployment playbooks that support both cloud-based and on-premise scenarios, including tested deployment templates, security baselines, and transition pathways for hybrid configurations. Invest in change management services-training, role-based learning pathways, and on-site support-to accelerate adoption and to secure measurable safety and efficiency outcomes. From a commercial perspective, consider offering outcome-linked service bundles or performance guarantees that align incentives with provider goals.

Finally, strengthen supply chain resilience by diversifying component sourcing, formalizing contingency plans, and offering transparent disclosure of sourcing and logistics. Governance and regulatory readiness should be continuous programs rather than discrete activities, and vendors should proactively engage with clinical and regulatory stakeholders to ease certification and compliance pathways. Taken together, these measures will materially reduce deployment risk and increase the likelihood of achieving sustained clinical and operational benefits

Outlining a rigorous mixed-methods research methodology combining primary stakeholder engagement, technical audits, and multi-source data triangulation for market evidence

The research underpinning this analysis combined mixed methods to ensure robustness and practical relevance. Primary research included structured interviews with clinicians, health system executives, IT leaders, and vendor product managers to capture firsthand perspectives on clinical workflow needs, procurement priorities, and implementation challenges. These conversations were supplemented by technical audits of representative solutions to evaluate integration architectures, security postures, and functional coverage across chemotherapy management, radiation planning, imaging, and laboratory interfaces.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory guidance, standards documentation, and publicly available product specifications to contextualize vendor claims and to identify domain-specific best practices. Data triangulation was applied to reconcile differing viewpoints and to validate thematic findings across sources. Analytical methods included capability mapping against the defined segmentation framework, scenario analysis to stress-test supply chain and deployment assumptions, and gap analysis to highlight unmet clinical and operational needs.

Limitations are acknowledged: stakeholder perspectives reflect current adoption patterns and organizational priorities at the time of inquiry, and implementations can vary widely by institution. Nonetheless, the methodology prioritizes transparency, reproducibility, and practitioner validation to produce insights that are directly actionable for product, clinical, and commercial leaders

Concluding strategic synthesis that aligns clinical priorities, technology investments, and policy considerations to strengthen oncology information system outcomes and ROI

The synthesis of clinical priorities, technological capabilities, and policy drivers leads to a clear strategic imperative: oncology information systems must be both clinically intelligent and operationally adaptable. Stakeholders should prioritize solutions that demonstrate seamless interoperability across chemotherapy systems, radiation planning, imaging archives, laboratory data, and electronic records while also supporting advanced decision support, scheduling, and compliance workflows. Equally important is the need for flexible deployment models and service constructs that reduce implementation friction and support incremental rollouts.

Organizations that succeed will combine robust clinical validation, modular architectures, and strong local implementation capabilities to deliver measurable improvements in patient safety and care coordination. Supply chain resilience and procurement agility have emerged as additional differentiators, particularly in environments affected by policy-driven cost pressures. Finally, the pursuit of clinician-centric design and continuous performance monitoring will determine adoption and long-term value realization. This conclusion underscores an actionable focus: align investments with demonstrable clinical outcomes, prioritize interoperability, and institutionalize governance to sustain performance over time

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. AI-driven predictive analytics integration in oncology information systems for personalized treatment planning
  • 5.2. Integration of comprehensive genomic sequencing data into oncology information platforms for precision medicine
  • 5.3. Cloud-based oncology information systems enabling secure remote collaboration across multidisciplinary care teams
  • 5.4. Implementation of HL7 FHIR interoperability standards for seamless oncology data exchange and reporting
  • 5.5. Advanced patient-reported outcome tracking modules for real-time quality-of-life insights in cancer care
  • 5.6. Machine learning algorithms predicting adverse drug reactions from electronic oncology records for improved safety monitoring
  • 5.7. Teleoncology virtual care integration in oncology information systems to expand rural patient access and support

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oncology Information Systems Market, by Offering

  • 8.1. Services
    • 8.1.1. Consulting & Training
    • 8.1.2. Installation & Integration
    • 8.1.3. Maintenance & Support
  • 8.2. Solution
    • 8.2.1. Chemotherapy Information System
    • 8.2.2. Clinical Integration Solutions
    • 8.2.3. Laboratory Information Systems (LIS)
    • 8.2.4. Medical Image Analysis & Advanced Visualization
    • 8.2.5. Oncology Electronic Health Record (EHR)
    • 8.2.6. Picture Archiving & Communication System (PACS) & Vendor-Neutral Archive (VNA)
    • 8.2.7. Radiation Treatment Planning System
    • 8.2.8. Radiology Information Systems (RIS)

9. Oncology Information Systems Market, by Functionality

  • 9.1. Billing & Revenue Cycle Management
  • 9.2. Clinical Decision Support
  • 9.3. Patient Information & Care Management
  • 9.4. Regulatory Compliance & Reporting
  • 9.5. Treatment Planning & Scheduling

10. Oncology Information Systems Market, by Deployment Mode

  • 10.1. Cloud-Based
  • 10.2. On-Premise

11. Oncology Information Systems Market, by Application

  • 11.1. Medical Oncology
  • 11.2. Radiation Oncology
  • 11.3. Surgical Oncology

12. Oncology Information Systems Market, by End User

  • 12.1. Ablation & Cancer Care Centers
  • 12.2. Hospitals & Diagnostic Imaging Centers
  • 12.3. Research Facilities

13. Oncology Information Systems Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Oncology Information Systems Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Oncology Information Systems Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Accuray Incorporated
    • 16.3.2. Advanced Data Systems Corporation
    • 16.3.3. CompuGroup Medical, Inc.
    • 16.3.4. CureMD.com, Inc.
    • 16.3.5. DOSIsoft SA
    • 16.3.6. Elekta AB
    • 16.3.7. EndoSoft LLC by Utech Products Inc.
    • 16.3.8. Epic Systems Corporation
    • 16.3.9. F. Hoffmann-La Roche Ltd.
    • 16.3.10. FUJIFILM Corporation
    • 16.3.11. GE HealthCare Technologies Inc.
    • 16.3.12. International Business Machines Corporation
    • 16.3.13. Karkinos Healthcare Private Limited
    • 16.3.14. McKesson Corporation
    • 16.3.15. Medical Information Technology, Inc.
    • 16.3.16. MICA Information Systems, Inc.
    • 16.3.17. N-Power Medicine, Inc.
    • 16.3.18. NextGen Healthcare, Inc.
    • 16.3.19. Novarad Corporation
    • 16.3.20. Oracle Corporation
    • 16.3.21. RaySearch Laboratories
    • 16.3.22. Royal Philips
    • 16.3.23. Tempus AI, Inc.
    • 16.3.24. Varian Medical Systems, Inc. by Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ONCOLOGY INFORMATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA ONCOLOGY INFORMATION SYSTEM